文献速递慢病防控与筛查免疫规划卫生政策与健康促进

2018年宫颈癌发病与死亡的全球估计:一项全球分析

Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.
PubMed 文献 · Lancet Glob Health · 2019-12-04

宫颈癌是女性第四常见癌症,在中非、西非、东非和南非是女性癌症相关死亡的首位原因。

要点

  • 宫颈癌是女性第四常见癌症,位列乳腺癌、结直肠癌和肺癌之后。

核心结论

  • 宫颈癌仍是影响中年女性的主要公共卫生问题,尤其在资源较少国家;全球扩大HPV疫苗接种和HPV筛查(包括自采样)有潜力使宫颈癌在未来数十年成为罕见病。

研究设计与样本

  • 全球分析,使用全球癌症观测站2018年数据库185个国家的癌症估计数据,采用基于人群癌症登记来源信息可用性和质量的分层方法估计宫颈癌发病率。
  • 宫颈癌死亡率估计使用WHO死亡数据库;国家按人类发展指数分为高资源或低资源国家。

主要发现

  • 全球宫颈癌估计年龄标化发病率为13.1/10万女性,国家间差异大,范围从低于2/10万至75/10万女性。
  • 宫颈癌是东非、西非、中非和南非女性癌症相关死亡的首位原因;斯威士兰估计发病率最高,约6.5%的女性在75岁前发生宫颈癌。

关键数值与推荐

  • 全球宫颈癌诊断平均年龄为53岁,范围从44岁(瓦努阿图)至68岁(新加坡)。
  • 全球宫颈癌死亡平均年龄为59岁,范围从45岁(瓦努阿图)至76岁(马提尼克)。
  • 在评估的185个国家中,有146个(79%)国家宫颈癌位列影响45岁以下女性的前三位癌症。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The knowledge that persistent human papillomavirus (HPV) infection is the main cause of cervical cancer has resulted in the development of prophylactic vaccines to prevent HPV infection and HPV assays that detect nucleic acids of the virus. WHO has launched a Global Initiative to scale up preventive, screening, and treatment interventions to eliminate cervical cancer as a public health problem during the 21st century. Therefore, our study aimed to assess the existing burden of cervical cancer as a baseline from which to assess the effect of this initiative. METHODS: For this worldwide analysis, we used data of cancer estimates from 185 countries from the Global Cancer Observatory 2018 database. We used a hierarchy of methods dependent on the availability and quality of the source information from population-based cancer registries to estimate incidence of cervical cancer. For estimation of cervical cancer mortality, we used the WHO mortality database. Countries were grouped in 21 subcontinents and were also categorised as high-resource or lower-resource countries, on the basis of their Human Development Index. We calculated the number of cervical cancer cases and deaths in a given country, directly age-standardised incidence and mortality rate of cervical cancer, indirectly standardised incidence ratio and mortality ratio, cumulative incidence and mortality rate, and average age at diagnosis. FINDINGS: Approximately 570 000 cases of cervical cancer and 311 000 deaths from the disease occurred in 2018. Cervical cancer was the fourth most common cancer in women, ranking after breast cancer (2·1 million cases), colorectal cancer (0·8 million) and lung cancer (0·7 million). The estimated age-standardised incidence of cervical cancer was 13·1 per 100 000 women globally and varied widely among countries, with rates ranging from less than 2 to 75 per 100 000 women. Cervical cancer was the leading cause of cancer-related death in women in eastern, western, middle, and southern Africa. The highest incidence was estimated in Eswatini, with approximately 6·5% of women developing cervical cancer before age 75 years. China and India together contributed more than a third of the global cervical burden, with 106 000 cases in China and 97 000 cases in India, and 48 000 deaths in China and 60 000 deaths in India. Globally, the average age at diagnosis of cervical cancer was 53 years, ranging from 44 years (Vanuatu) to 68 years (Singapore). The global average age at death from cervical cancer was 59 years, ranging from 45 years (Vanuatu) to 76 years (Martinique). Cervical cancer ranked in the top three cancers affecting women younger than 45 years in 146 (79%) of 185 countries assessed. INTERPRETATION: Cervical cancer continues to be a major public health problem affecting middle-aged women, particularly in less-resourced countries. The global scale-up of HPV vaccination and HPV-based screening-including self-sampling-has potential to make cervical cancer a rare disease in the decades to come. Our study could help shape and monitor the initiative to eliminate cervical cancer as a major public health problem. FUNDING: Belgian Foundation Against Cancer, DG Research and Innovation of the European Commission, and The Bill & Melinda Gates Foundation.

来源:Lancet Glob Health,查看原文。版权归原作者所有。

引用

  1. Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2019. PMID: 31812369. doi:10.1016/S2214-109X(19)30482-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。